Alnylam Pharmaceuticals
ALNY
#564
Rank
NZ$74.50 B
Marketcap
NZ$558.40
Share price
1.20%
Change (1 day)
35.79%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

Quarterly Reports

Thumbnail Alnylam Pharmaceuticals
 Quarterly Report 2025-q3

Quarterly Report 2025-q3

Language: English

View Quarterly Report